Frequently Asked Questions
What is NeuroStar TMS Therapy?
- The NeuroStar TMS Therapy system is the first and only TMS Therapy® device cleared by the FDA for the treatment of depression.
- TMS Therapy is a non-systemic (does not circulate in the bloodstream throughout the body) and non-invasive (does not involve surgery) form of neuromodulation, which stimulates nerve cells in an area of the brain that is linked to depression, by delivering highly focused MRI-strength magnetic pulses.
- Patients being treated by NeuroStar TMS Therapy do not require anesthesia or sedation and remain awake and alert.
- It is a 37-minute outpatient procedure that is prescribed by a psychiatrist and performed in a psychiatrist’s office.
- The treatment is typically administered daily for 4-6 weeks.
What happens during TMS Therapy? What’s the Mechanism of Action?
- During NeuroStar TMS Therapy, pulsed magnetic fields are repetitively transmitted into the left prefrontal cortex, the part of the brain that is thought to regulate mood, in order to stimulate the firing of neurons (nerve cells).
- This is believed to trigger a cascade of neurochemical events, including the release of neurotransmitters (such as serotonin, norepinephrine, and dopamine) and to help normalize neurotransmitter function.
How long does a patient undergo NeuroStar TMS therapy?
- In clinical trials, patients received NeuroStar TMS Therapy 5 times per week for 37 minutes each session for 4-6 weeks.
- Patients should be treated for a minimum of four weeks with additional treatments based on clinical judgment.